More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$15.11B
EPS
15.89
P/E ratio
26.3
Price to sales
4.46
Dividend yield
--
Beta
1.151462
Previous close
$536.17
Today's open
$537.28
Day's range
$525.45 - $538.60
52 week range
$306.70 - $628.92
show more
CEO
August J. Troendle
Employees
6200
Headquarters
Cincinnati, OH
Exchange
Nasdaq Global Select
Shares outstanding
28559689
Issue type
Common Stock
Healthcare
Biotechnology & Life Sciences
CON vs. MEDP: Which Stock Is the Better Value Option?
Investors interested in Medical Services stocks are likely familiar with Concentra Group (CON) and Medpace (MEDP). But which of these two stocks presents investors with the better value opportunity right now?
Zacks Investment Research • 18 hours ago

Why Medpace (MEDP) Dipped More Than Broader Market Today
Medpace (MEDP) closed at $530.19 in the latest trading session, marking a -1.49% move from the prior day.
Zacks Investment Research • Jul 13, 2026

Medpace Growth Trends Show How CRO Demand Is Shifting in 2026
MEDP's 2026 outlook highlights shifting CRO demand, longer award-to-revenue timing and steady margins, while AI investment delays near-term productivity gains.
Zacks Investment Research • Jul 7, 2026

Medpace Stock Outlook Turns on Backlog Quality and Cancellations
MEDP's outlook hinges on whether strong backlog quality and metabolic demand can offset rising cancellations and softer proposal activity.
Zacks Investment Research • Jul 6, 2026

Medpace (MEDP) Ascends While Market Falls: Some Facts to Note
In the closing of the recent trading day, Medpace (MEDP) stood at $543.57, denoting a +2.64% move from the preceding trading day.
Zacks Investment Research • Jul 1, 2026

CON or MEDP: Which Is the Better Value Stock Right Now?
Investors looking for stocks in the Medical Services sector might want to consider either Concentra Group (CON) or Medpace (MEDP). But which of these two stocks offers value investors a better bang for their buck right now?
Zacks Investment Research • Jun 29, 2026

Medpace (MEDP) Advances While Market Declines: Some Information for Investors
Medpace (MEDP) reached $519.96 at the closing of the latest trading day, reflecting a +1.4% change compared to its last close.
Zacks Investment Research • Jun 25, 2026

Medpace Holdings, Inc. to Report Second Quarter 2026 Financial Results on July 22, 2026
CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its second quarter 2026 financial results after the market close on Wednesday, July 22, 2026. The Company will host a conference call the following morning, Thursday, July 23, 2026, at 9:00 a.m. ET to discuss these results. To participate in the conference call, interested parties must register in advance by clicking on this link. While it is not required, it is recommended you joi.
Business Wire • Jun 16, 2026

Medpace (MEDP) Suffers a Larger Drop Than the General Market: Key Insights
Medpace (MEDP) closed the most recent trading day at $461.6, moving 1.26% from the previous trading session.
Zacks Investment Research • Jun 16, 2026

Why the Market Dipped But Medpace (MEDP) Gained Today
Medpace (MEDP) closed at $466.79 in the latest trading session, marking a +1.94% move from the prior day.
Zacks Investment Research • Jun 9, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Medpace Holdings Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.